UK markets close in 2 hours 4 minutes

Xvivo Perfusion AB (publ) (0RKL.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
275.50+8.00 (+2.99%)
As of 01:03PM GMT. Market open.

Xvivo Perfusion AB (publ)

Mässans gata 10
Gothenburg 412 51
Sweden
46 3 17 88 21 50
https://www.xvivoperfusion.com

Sector(s)
Industry
Full-time employees94

Key executives

NameTitlePayExercisedYear born
Mr. Dag AnderssonPres & CEON/AN/A1961
Dr. Magnus NilssonSr. AdvisorN/AN/A1956
Mr. Kristoffer NordstromCFO & Investor RelationsN/AN/A1985
Mr. Christoffer RosenbladCOO & Deputy CEON/AN/A1975
Ms. Katrin GisselfaltGlobal Quality Assurance & Regulatory Affairs DirectorN/AN/A1969
Mr. Andreas Wallinder M.D., Ph.D.Chief Medical OfficerN/AN/A1977
Mr. Johan HolmstromChief Commercial OfficerN/AN/A1970
Ms. Charlotte WalldalGlobal R&D directorN/AN/A1967
Mr. Christer de FlonMang.N/AN/A1949
Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.

Description

Xvivo Perfusion AB (publ), a medical technology company, develops solutions for organ, tissue, and cell preservation and perfusion in connection with transplantation in Sweden, the Americas, rest of Europe, the Middle East, Africa, and the Asia Pacific. The company offers XVIVO Perfusion System (XPS), an integrated off-the-shelf cardiac bypass system that includes various components needed to safely run normothermic ex-vivo lung perfusion (EVLP); XPS Disposable Lung Kit that contains disposables and pre-packed products to suit requirement for sterility; and STEEN Solution, a buffered extracellular solution optimally designed to perfuse the isolated donor lung during EVLP. It also provides Perfadex, a buffered extracellular colloid-based electrolyte preservation solution; Perfadex Plus, an extracellular, low potassium, dextran-based electrolyte preservation solution; XVIVO Silicone Tubing Set for rapid flushing of donor lungs during procurement; and XVIVO LS and XVIVO Disposable Lung Set, a device for EVLP. In addition, the company offers XVIVO Organ Chamber, a single-use sterile disposable container intended to be used as a temporary receptacle for isolated lungs in preparation for eventual transplantation into a recipient; and XVIVO Lung Cannula Set, a single-use, sterile disposable product. Xvivo Perfusion AB (publ) was founded in 1998 and is headquartered in Gothenburg, Sweden.

Corporate governance

Xvivo Perfusion AB (publ)’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.